Joseph H. Capper

Joseph H. Capper joined the Board of Directors of Anika in May 2024. Mr. Capper is a highly accomplished healthcare executive, bringing nearly 30 years of experience in MedTech and Life Sciences leadership roles and a track record of substantial value creation. Mr. Capper currently serves as CEO and a director of MIMEDX, a leader in placental biologics, a position he has held since 2023. Prior to becoming the CEO and a director of MIMEDX, Mr. Capper previously served as the CEO of BioTelemetry from 2010 to 2021, guiding the company through a significant turn-around, which culminated with its acquisition by Royal Philips for $2.8 billion. Prior to BioTelemetry, he served as President and CEO of both Home Diagnostics and CCS Medical. Mr. Capper brings with him a wealth of commercial experience, having held several leadership roles earlier in his career during the decade he spent with Bayer AG. Additionally, he was an officer in the U.S. Navy serving with distinction as a naval aviator. Mr. Capper received his undergraduate degree in Accounting from West Chester University and MBA in International Finance from George Washington University. Mr. Capper serves as a member of the Capital Allocation Committee.